Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Personalized treatment of prostate cancer: better knowledge of the patient, the disease and the medicine

Published:2016-10 Issue:20 Volume:12 Page:2359-2361
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Aoun Fouad¹²,Rassy Elie El³,Assi Tarek³,Kattan Joseph³

Affiliation:

1. Department of Urology, Jules Bordet Institute, Université Libre de Bruxelles, Belgium

2. Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon

3. Department of Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fon-2016-0292

Reference18 articles.

1. Personalized medicine-based strategy for prostate cancer

2. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches

3. Integrative Clinical Genomics of Advanced Prostate Cancer

4. Abiraterone and Increased Survival in Metastatic Prostate Cancer

5. Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural model for formation of packages of clinical and diagnostic tests to organize personalized medical care for patients with malignant tumors of the prostate gland;Medical Journal of the Russian Federation;2021-06-29

2. Identification of marker genes and cell subtypes in castration-resistant prostate cancer cells;Journal of Cancer;2021

3. Molecular alterations and precision medicine in prostate cancer;Precision Medicine for Investigators, Practitioners and Providers;2020

4. The optimal treatment of metastatic hormone-naive prostate cancer: abiraterone acetate or docetaxel?;Future Oncology;2017-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3